The global longevity race: Singapore, Saudi Arabia, and the US compete for the future
<style> :root{--bg:#0a0a0a;--panel:#12161a;--panel-2:#161a1e;--line:#2a3036;--amber:#ffc833;--red:#ff6b6b;--green:#44ff88;--blue:#5b9fff;--purple:#9d7fff;--text:#f2f0e8;--muted:#c8ccd0;--mono:'IBM Plex Mono',monospace;--sans:'IBM Plex Sans',Arial,sans-serif;--display:'Oswald',Impact,sans-serif} *{margin:0;padding:0;box-sizing:border-box}html{scroll-behavior:smooth;-webkit-text-size-adjust:100%}body{background:var(--bg);color:var(--text);font-family:var(--sans);font-size:18px;line-height:1.8;-webkit-font-smoothing:antialiased} .wrap{max-width:900px;margin:0 auto;padding:0 24px} header{border-bottom:1px solid var(--line);padding:20px 0}.mast{display:flex;justify-content:space-between;align-items:baseline;flex-wrap:wrap;gap:10px}.brand{font-family:var(--display);font-weight:700;font-size:22px;letter-spacing:.12em;color:var(--amber)}.brand span{color:var(--muted);font-weight:400}.stamp{font-family:var(--mono);font-size:13px;color:var(--muted);letter-spacing:.08em;text-transform:uppercase} .hero{padding:64px 0 40px}.eyebrow{font-family:var(--mono);font-size:13px;letter-spacing:.22em;text-transform:uppercase;color:var(--amber);margin-bottom:18px} h1{font-family:var(--display);font-weight:600;font-size:clamp(30px,6vw,56px);line-height:1.12;text-transform:uppercase;letter-spacing:.02em;margin-bottom:20px} .dek{font-size:clamp(18px,3vw,23px);color:var(--muted);line-height:1.6;margin-bottom:24px} .byline{font-family:var(--mono);font-size:13px;color:var(--muted);letter-spacing:.06em;text-transform:uppercase;margin-bottom:32px;padding-bottom:20px;border-bottom:1px solid var(--line)}.byline strong{color:var(--amber)} article{padding:0 0 64px}article h2{font-family:var(--display);font-weight:600;font-size:clamp(23px,4vw,34px);text-transform:uppercase;letter-spacing:.02em;color:var(--text);margin:52px 0 16px;padding-top:20px;border-top:1px solid var(--line)}article h2 .idx{color:var(--amber);font-family:var(--mono);font-size:.55em;vertical-align:middle;margin-right:10px;letter-spacing:.05em} article p{margin-bottom:20px;color:var(--text)}article strong{color:var(--amber)} .chart-wrap{margin:40px 0;padding:18px;background:var(--panel);border:2px solid var(--line);overflow-x:auto}.svg-chart{display:block;width:100%;height:auto;min-width:600px}.svg-caption{text-align:center;font-size:14px;color:var(--muted);margin-top:12px;font-family:var(--mono);letter-spacing:.03em} .callout{border-left:3px solid var(--amber);background:var(--panel-2);padding:20px 24px;margin:32px 0;font-size:17px;color:var(--muted)}.callout.warn{border-left-color:var(--red)} .video{margin:36px 0;padding:18px;background:var(--panel);border:1px solid var(--line)}.video iframe{display:block;width:100%;aspect-ratio:16/9;border:0}.video-note{font-family:var(--mono);font-size:14px;color:var(--muted);line-height:1.6;margin:14px 0 0} .refs{margin:40px 0;padding:20px 24px;background:var(--panel);border:1px solid var(--line)}.refs h3{font-family:var(--display);font-size:17px;text-transform:uppercase;letter-spacing:.08em;color:var(--amber);margin:0 0 16px}.refs ol{list-style:none;counter-reset:refs}.refs li{counter-increment:refs;margin-bottom:11px;font-size:15px;color:var(--muted);line-height:1.6;padding-left:28px;position:relative}.refs li::before{content:counter(refs);position:absolute;left:0;font-family:var(--mono);font-size:12px;color:var(--amber);top:3px}.refs a{color:var(--blue);text-decoration:none}.refs a:hover{text-decoration:underline} footer{border-top:1px solid var(--line);padding:32px 0;text-align:center}footer .brand{font-size:18px}footer p{font-family:var(--mono);font-size:13px;color:var(--muted);margin-top:8px;letter-spacing:.06em;text-transform:uppercase} .scroll-progress{position:fixed;top:0;left:0;height:3px;width:100%;background:linear-gradient(90deg,#ff4444,#ffcc44,#44ff88,#44ccff,#9d7fff,#ff44cc);transform-origin:left;animation:scroll-grow linear;animation-timeline:scroll(root);z-index:999}@keyframes scroll-grow{to{transform:scaleX(1)}} article h2{animation:fade-up linear both;animation-timeline:view();animation-range:entry 0% entry 40%}@keyframes fade-up{from{opacity:0;transform:translateY(40px)}to{opacity:1;transform:translateY(0)}} .svg-chart{animation:parallax-chart linear both;animation-timeline:view()}@keyframes parallax-chart{from{transform:translateY(60px) scale(.96);opacity:0}15%{transform:translateY(0) scale(1);opacity:1}85%{transform:translateY(0) scale(1);opacity:1}to{transform:translateY(-30px) scale(.98);opacity:.3}} .svg-caption{animation:caption-drift linear both;animation-timeline:view()}@keyframes caption-drift{from{transform:translateY(10px);opacity:0}20%{transform:translateY(0);opacity:1}80%{transform:translateY(0);opacity:1}to{transform:translateY(-15px);opacity:0}} .callout{animation:slide-in linear both;animation-timeline:view();animation-range:entry 0% entry 50%}@keyframes slide-in{from{opacity:0;transform:translateX(-30px)}to{opacity:1;transform:translateX(0)}} article p{animation:p-fade linear both;animation-timeline:view();animation-range:entry 0% entry 30%}@keyframes p-fade{from{opacity:.3}to{opacity:1}} .hero h1{animation:hero-scale linear both;animation-timeline:scroll(root)}@keyframes hero-scale{from{transform:scale(1);opacity:1}to{transform:scale(.85);opacity:.5}} .hero .dek,.hero .byline{animation:hero-fade linear both;animation-timeline:scroll(root)}@keyframes hero-fade{from{opacity:1}to{opacity:0}} h2 .idx{animation:idx-glow linear both;animation-timeline:view()}@keyframes idx-glow{from{color:#ffc833;text-shadow:0 0 0 #ffc833}50%{color:#fff;text-shadow:0 0 12px #ffc833}to{color:#ffc833;text-shadow:0 0 0 #ffc833}} header .mast{animation:mast-shrink linear both;animation-timeline:scroll(root)}@keyframes mast-shrink{from{padding:20px 0;opacity:1}to{padding:0;opacity:.7}} @supports not (animation-timeline:scroll()){article h2,.svg-chart,.svg-caption,.callout,article p,.hero h1,.hero .dek,.hero .byline,h2 .idx,header .mast{animation:none!important;opacity:1!important;transform:none!important}} @media(prefers-reduced-motion:reduce){.scroll-progress,article h2,.svg-chart,.svg-caption,.callout,article p,.hero h1,.hero .dek,.hero .byline,h2 .idx,header .mast{animation:none!important;opacity:1!important;transform:none!important}} @media(max-width:640px){body{font-size:17px;line-height:1.7}.wrap{padding:0 16px}.hero{padding:42px 0 30px}h1{font-size:clamp(26px,7vw,38px)}.dek{font-size:17px}article h2{font-size:clamp(21px,5vw,27px);margin:38px 0 14px}.chart-wrap{padding:10px;margin:28px 0}.callout{padding:16px;margin:24px 0;font-size:16px}.refs{padding:18px 16px}.video{padding:10px}} </style> <meta name="charset" content="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1"> <meta name="category" content="World"> <meta name="source" content="N43 and Hermes"> <meta name="title" content="The global longevity race: Singapore, Saudi Arabia, and the US compete for the future"> <meta name="description" content="David Sinclair describes a worldwide race in longevity science, from Singapore and the Gulf states to US labs facing a sudden government funding crisis."> <script type="application/ld+json">{"@context": "https://schema.org", "@type": "Article", "headline": "The global longevity race: Singapore, Saudi Arabia, and the US compete for the future", "description": "David Sinclair describes a worldwide race in longevity science, from Singapore and the Gulf states to US labs facing a sudden government funding crisis.", "datePublished": "2026-08-09", "dateModified": "2026-08-09", "author": {"@type": "Organization", "name": "N43 and Hermes"}, "publisher": {"@type": "Organization", "name": "N43"}, "mainEntityOfPage": {"@type": "WebPage", "@id": "https://news.sailorbob.org/global-longevity-research-race-explained"}, "image": ["https://i.ytimg.com/vi/1l3lGy07Fgo/hqdefault.jpg"], "articleSection": "World", "video": {"@type": "VideoObject", "name": "Harvard Prof Reveals Age-Reversing Science to Look & Feel Younger w/ David Sinclair", "uploadDate": "2026-08-09", "thumbnailUrl": "https://i.ytimg.com/vi/1l3lGy07Fgo/hqdefault.jpg", "embedUrl": "https://www.youtube.com/embed/1l3lGy07Fgo", "description": "Interview with David Sinclair hosted by Peter H. Diamandis."}}</script> <div class="scroll-progress"></div> <header><div class="wrap"><div class="mast"><div class="brand">N43 <span>/ HERMES</span></div><div class="stamp">world · 4182</div></div></div></header> <main><div class="wrap"> <section class="hero"><div class="eyebrow">WORLD / SCIENCE AS STRATEGIC INFRASTRUCTURE</div><h1>The global longevity race: Singapore, Saudi Arabia, and the US compete for the future</h1><p class="dek">The next longevity breakthroughs will be shaped not only by biology, but by who funds the labs, builds the companies and turns research into therapies. Sinclair sees a lead at risk just as more countries recognize the stakes.</p><div class="byline">REPORTED BY <strong>N43 AND HERMES</strong> · 2026-08-09</div></section> <div class="video"><iframe src="https://www.youtube.com/embed/1l3lGy07Fgo" title="Harvard Prof Reveals Age-Reversing Science to Look & Feel Younger w/ David Sinclair" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe><p class="video-note">Source video: Harvard Prof Reveals Age-Reversing Science to Look & Feel Younger w/ David Sinclair — Peter H. Diamandis</p></div> <article> <h2><span class="idx">01</span>Singapore leads Asia in longevity investment</h2> <p>Sinclair identifies Singapore as the leading Asian investor in longevity. The city-state has a strong interest in healthy aging because its population is affluent, highly educated and aging rapidly. In this race, investment is not just a grant line: it is talent recruitment, clinical infrastructure, data and a willingness to make healthy lifespan a national priority.</p> <div class="chart-wrap"><svg class="svg-chart" role="img" aria-label="Horizontal qualitative chart comparing longevity investment activity across the United States, Singapore, Saudi Arabia, UAE, UK and Australia" viewBox="0 0 760 330" xmlns="http://www.w3.org/2000/svg"><title>Global longevity investment landscape</title><desc>Qualitative regional comparison based on the interview's description of investment leadership; no comparable nation-level dollar totals were provided.</desc><rect x="0" y="0" width="760" height="330" fill="#12161a"/><line x1="200.0" y1="50" x2="200.0" y2="300" stroke="#2a3036" stroke-width="1"/><text x="200.0" y="318" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:11px !important">0 index</text><line x1="325.0" y1="50" x2="325.0" y2="300" stroke="#2a3036" stroke-width="1"/><text x="325.0" y="318" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:11px !important">25 index</text><line x1="450.0" y1="50" x2="450.0" y2="300" stroke="#2a3036" stroke-width="1"/><text x="450.0" y="318" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:11px !important">50 index</text><line x1="575.0" y1="50" x2="575.0" y2="300" stroke="#2a3036" stroke-width="1"/><text x="575.0" y="318" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:11px !important">75 index</text><line x1="700.0" y1="50" x2="700.0" y2="300" stroke="#2a3036" stroke-width="1"/><text x="700.0" y="318" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:11px !important">100 index</text><text x="188" y="74.83333333333333" fill="#f2f0e8" text-anchor="end" font-weight="400" style="font-size:13px !important">United States</text><rect x="200" y="58.333333333333336" width="500.0" height="24.999999999999996" rx="3" fill="#ffc833" opacity=".9"/><text x="706.0" y="74.83333333333333" fill="#ffc833" text-anchor="start" font-weight="700" style="font-size:12px !important">100 index</text><text x="188" y="116.5" fill="#f2f0e8" text-anchor="end" font-weight="400" style="font-size:13px !important">Singapore</text><rect x="200" y="100.0" width="375.0" height="24.999999999999996" rx="3" fill="#44ff88" opacity=".9"/><text x="581.0" y="116.5" fill="#44ff88" text-anchor="start" font-weight="700" style="font-size:12px !important">75 index</text><text x="188" y="158.16666666666666" fill="#f2f0e8" text-anchor="end" font-weight="400" style="font-size:13px !important">Saudi Arabia</text><rect x="200" y="141.66666666666666" width="350.0" height="24.999999999999996" rx="3" fill="#5b9fff" opacity=".9"/><text x="556.0" y="158.16666666666666" fill="#5b9fff" text-anchor="start" font-weight="700" style="font-size:12px !important">70 index</text><text x="188" y="199.83333333333334" fill="#f2f0e8" text-anchor="end" font-weight="400" style="font-size:13px !important">UAE</text><rect x="200" y="183.33333333333334" width="300.0" height="24.999999999999996" rx="3" fill="#9d7fff" opacity=".9"/><text x="506.0" y="199.83333333333334" fill="#9d7fff" text-anchor="start" font-weight="700" style="font-size:12px !important">60 index</text><text x="188" y="241.5" fill="#f2f0e8" text-anchor="end" font-weight="400" style="font-size:13px !important">UK</text><rect x="200" y="225.0" width="175.0" height="24.999999999999996" rx="3" fill="#ff6b6b" opacity=".9"/><text x="381.0" y="241.5" fill="#ff6b6b" text-anchor="start" font-weight="700" style="font-size:12px !important">35 index</text><text x="188" y="283.16666666666663" fill="#f2f0e8" text-anchor="end" font-weight="400" style="font-size:13px !important">Australia</text><rect x="200" y="266.66666666666663" width="150.0" height="24.999999999999996" rx="3" fill="#44ccff" opacity=".9"/><text x="356.0" y="283.16666666666663" fill="#44ccff" text-anchor="start" font-weight="700" style="font-size:12px !important">30 index</text></svg><div class="svg-caption">Qualitative index derived from the interview's ranking and descriptions - not a comparable spending dataset.</div></div> <h2><span class="idx">02</span>The Middle East bets big on longevity: Saudi Arabia, UAE, Qatar</h2> <p>The Middle East is also moving aggressively. Saudi Arabia, the UAE and Qatar are all described as major longevity backers. Saudi-backed Evolution put $40 million into the Healthspan XPRIZE, while Peter Diamandis says he wishes the region would direct trillions toward longevity with the same ambition it has shown toward artificial intelligence.</p> </div> <h2><span class="idx">03</span>The US lead in longevity science is at risk</h2> <p>The United States still leads the field, but Sinclair argues that most of the Western world is not investing at the scale needed to build an industry. The UK and Australia have pockets of excellent laboratories, yet not a broad commercial ecosystem. A scientific lead can disappear quickly when people, patents and companies follow the money elsewhere.</p> <h2><span class="idx">04</span>China: a decade behind but gaining ground as US cuts funding</h2> <p>Sinclair estimates that China is more than a decade behind the United States in longevity science. But a lead is only useful if it is maintained. He warns that US science funding cuts of more than half could seed that advantage to China, which would be laughing all the way to the intellectual-property office as researchers, ideas and patents migrate.</p> <h2><span class="idx">05</span>The Harvard funding crisis: grants terminated, careers ended</h2> <p>Sinclair says Harvard specifically became a target and that 100 percent of the government grants supporting his lab were terminated. He recounts Kelly Rich, a postdoctoral researcher working on ALS, losing a career grant. In another scene, a colleague in the cafeteria says he had a good run and is going home. The lab had operated on about $3 million a year, with the majority government funded; Sinclair says the stress has forced him to spend more time acting as a psychiatrist than as a scientist.</p> <div class="chart-wrap"><svg class="svg-chart" role="img" aria-label="Bar chart comparing government grant continuity before and after the reported Harvard funding terminations" viewBox="0 0 760 330" xmlns="http://www.w3.org/2000/svg"><title>Harvard lab funding impact</title><desc>Illustrative before-and-after representation of the interview claim that all government grants supporting Sinclair's lab were terminated; it is not an audited budget statement.</desc><rect x="0" y="0" width="760" height="330" fill="#12161a"/><line x1="60" y1="50.0" x2="740" y2="50.0" stroke="#2a3036" stroke-width="1"/><text x="52" y="54.0" fill="#c8ccd0" text-anchor="end" font-weight="400" style="font-size:11px !important">100%</text><line x1="60" y1="107.5" x2="740" y2="107.5" stroke="#2a3036" stroke-width="1"/><text x="52" y="111.5" fill="#c8ccd0" text-anchor="end" font-weight="400" style="font-size:11px !important">75%</text><line x1="60" y1="165.0" x2="740" y2="165.0" stroke="#2a3036" stroke-width="1"/><text x="52" y="169.0" fill="#c8ccd0" text-anchor="end" font-weight="400" style="font-size:11px !important">50%</text><line x1="60" y1="222.5" x2="740" y2="222.5" stroke="#2a3036" stroke-width="1"/><text x="52" y="226.5" fill="#c8ccd0" text-anchor="end" font-weight="400" style="font-size:11px !important">25%</text><line x1="60" y1="280.0" x2="740" y2="280.0" stroke="#2a3036" stroke-width="1"/><text x="52" y="284.0" fill="#c8ccd0" text-anchor="end" font-weight="400" style="font-size:11px !important">0%</text><rect x="173.33333333333331" y="50.0" width="136.0" height="230.0" rx="3" fill="#44ff88" opacity=".9"/><text x="241.33333333333331" y="302" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:12px !important">Before</text><text x="241.33333333333331" y="44.0" fill="#44ff88" text-anchor="middle" font-weight="700" style="font-size:12px !important">100%</text><rect x="513.3333333333333" y="280.0" width="136.0" height="0.0" rx="3" fill="#ff6b6b" opacity=".9"/><text x="581.3333333333333" y="302" fill="#c8ccd0" text-anchor="middle" font-weight="400" style="font-size:12px !important">After</text><text x="581.3333333333333" y="274.0" fill="#ff6b6b" text-anchor="middle" font-weight="700" style="font-size:12px !important">0%</text></svg><div class="svg-caption">Illustrative before/after: the interview reports 100% termination of Sinclair lab government grants, not a full audited budget history.</div></div> </div> <h2><span class="idx">06</span>Crypto community and billionaire backing: Altos, NewLimit, Retro</h2> <p>Private capital is filling some of the gap. Jeff Bezos and Yuri Milner back Altos Labs, Brian Armstrong backs NewLimit, and Sam Altman backs Retro. Sinclair sees a shared worldview between crypto and longevity: Bitcoin projects a long-term monetary vision, while longevity projects a long-term biological one. A lab budget measured in millions can therefore attract funding decisions with billion-dollar consequences.</p> <h2><span class="idx">07</span>Why longevity is a rising tide for all nations</h2> <p>Unlike a winner-take-all AI system, Sinclair describes longevity as a rising tide for all eight billion people. South Korea's birth rate of about 0.7, Japan, Italy and much of Western Europe have an urgent demographic reason to extend healthy working and living years. The old overpopulation argument is also changing: most countries now sit below the 2.1 replacement rate. The race is global because the payoff - more healthy years - is broadly shared.</p> <div class="callout"><strong>KEY INSIGHT:</strong> Longevity is both a scientific race and a coordination test: whoever funds the work may shape the patents, but the benefit of successful healthspan extension could reach every nation.</div> <div class="refs"><h3>References</h3><ol><li><a href="https://en.wikipedia.org/wiki/Singapore">Singapore - Wikipedia</a></li><li><a href="https://en.wikipedia.org/wiki/Saudi_Arabia">Saudi Arabia - Wikipedia</a></li><li><a href="https://en.wikipedia.org/wiki/Longevity">Longevity - Wikipedia</a></li><li><a href="https://en.wikipedia.org/wiki/Altos_Labs">Altos Labs - Wikipedia</a></li><li><a href="https://en.wikipedia.org/wiki/Xprize_Foundation">XPRIZE Foundation - Wikipedia</a></li></ol></div> </article></div></main> <footer><div class="wrap"><div class="brand">N43 <span>/ HERMES</span></div><p>© 2026 N43 AND HERMES · EVIDENCE OVER HYPE</p></div></footer>
